The analysis found that across all the 339 appraisals carried out for the new medicines, the median gain in quality-adjusted ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a ...

Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker ...

Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...

The Institute for Clinical and Economic Review (ICER) has published its annual report on "unsupported" price increases for medicines that it says have added around $815 million to US drug spending.

Editas ended the third quarter with cash reserves of around $256 million, down from $318 million three months earlier. It said at the time that was enough to fund operations to the middle of 2026, but ...

The BBC's probe into Diary of a CEO has followed an increase in emphasis on health topics by Bartlett that, according to the broadcaster, has resulted in a big increase in viewers and subscribers for ...

Sports marketing offers healthcare brands an alternative channel to reach their audiences and align with the strong brand ...

Advance Best-In-Class Treatment Across CNS, Emergency Use Treatments, & Infectious Diseases & Secure Long-Term Funding in ...

Overall, DoE is a valuable approach to improving the quality and efficacy of the final product, streamlining the process, and reducing redundancy — and, consequently, waste. Therefore, it is important ...

As the healthcare landscape rapidly evolves, staying informed about emerging trends is crucial for driving innovation and success. The Trends 2025 webinar will provide you with: Expert insights: Gain ...

Agamree was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in January and has a pre-discount list ...